What Happened
- Only 0.09% of India's eligible population is currently registered as blood stem cell donors, creating a critical shortage for patients with aplastic anaemia and other blood disorders who need a transplant.
- Approximately 70% of patients with aplastic anaemia do not find a matched donor within their family and are entirely dependent on unrelated donors in national or global registries.
- A key barrier is genetic diversity: finding a 10/10 HLA (Human Leukocyte Antigen) match among unrelated individuals requires a large, ethnically diverse registry — India's registry is far too small relative to its population.
- India's largest blood stem cell donor registry, DATRI, has registered over 6.6 lakh donors — in a country of 1.4 billion, this covers a minuscule fraction of the eligible pool.
- A 32-year-old woman from Bengaluru recently donated blood stem cells to a 19-year-old patient with severe aplastic anaemia, highlighting both the life-saving potential and the rarity of such matches.
Static Topic Bridges
Aplastic Anaemia: The Disease and Why Transplant Is the Cure
Aplastic anaemia is a rare but life-threatening condition in which the bone marrow fails to produce sufficient blood cells — red cells, white cells, and platelets. It is caused by destruction of haematopoietic stem cells, often triggered by autoimmune processes, viral infections, or toxic chemical exposure. Without treatment, severe aplastic anaemia has a high mortality rate. The definitive treatment is a haematopoietic stem cell transplant (HSCT), which replaces the patient's defective marrow with healthy donor stem cells. Success depends critically on donor-recipient compatibility at the HLA loci.
- Aplastic anaemia affects approximately 2–3 people per million in Western countries; incidence may be higher in Asia.
- Classified as severe (SAA) or very severe (VSAA) based on blood cell count thresholds.
- First-line treatment is immunosuppressive therapy (IST) for patients who lack a matched donor or are older; HSCT is preferred for younger patients with a matched donor.
- Stem cells can be sourced from bone marrow, peripheral blood, or umbilical cord blood.
Connection to this news: The article highlights the structural bottleneck in HSCT treatment in India — not the procedure itself, but the inability to find the compatible donor that makes the procedure possible.
HLA Matching: The Science Behind Donor-Recipient Compatibility
Human Leukocyte Antigens (HLA) are proteins on cell surfaces encoded by genes in the Major Histocompatibility Complex (MHC) on chromosome 6. They act as identity markers that the immune system uses to distinguish "self" from "non-self." In transplantation, if donor and recipient HLA profiles do not match closely, the recipient's immune system attacks the transplanted cells, or the donor cells attack the recipient's body — a condition called Graft-versus-Host Disease (GvHD). The ideal match is 10/10 at the HLA-A, B, C, DRB1, and DQB1 loci. The probability of finding a 10/10 match among unrelated individuals in a registry depends heavily on the size and ethnic composition of that registry — populations with rare HLA haplotypes (common in Indian subpopulations) have far lower match probabilities.
- HLA genes are highly polymorphic — thousands of variants exist, making identical matches between unrelated individuals rare.
- Siblings have a 25% chance of being a 10/10 HLA match; the probability drops sharply for unrelated individuals.
- Population-specific HLA frequencies mean that Indian patients have the highest chance of finding a match in registries with significant Indian representation.
- DKMS-BMST (Bangalore-based) has analysed HLA frequency data from 130,518 Indian donors to map population-specific matching probabilities.
Connection to this news: The article's focus on the 0.09% registry participation rate reflects the core HLA science — India's genetic diversity and unique HLA haplotype distribution mean that Indian patients cannot simply rely on global registries populated largely by European donors.
India's Stem Cell Donor Registry Ecosystem
India has several blood stem cell donor registries working to build the national donor pool. The two principal ones are DATRI (India's largest, with over 6.6 lakh donors, established 2009) and DKMS-BMST (an offshoot of the German DKMS registry, operating from Bengaluru). Globally, over 30 million donors are registered across more than 80 registries in 57 countries, coordinated through Bone Marrow Donors Worldwide (BMDW). The low participation rate in India stems from a combination of low awareness, cultural hesitancy, logistical barriers to registration drives, and limited reach into rural areas where a significant portion of the eligible population lives.
- DATRI: Founded 2009, 6.6 lakh+ donors registered, headquartered in Chennai.
- DKMS-BMST: Bengaluru-based; focuses on South Asian population matching.
- Marrow Donor Registry India (MDRI) is a third registry.
- Global benchmark: Germany has ~10 million donors for a population of 84 million (~12%); India has ~6.6 lakh for 1.4 billion (~0.05%).
- Registration involves a simple cheek swab or blood test; donation (if matched) is a low-risk outpatient procedure in most cases.
Connection to this news: Bridging the gap between India's 0.09% and even a modest 1–2% registration rate would potentially save thousands of lives annually — but achieving this requires sustained public health campaigns, government support, and integration of registration drives with routine health check-up infrastructure.
Key Facts & Data
- India's stem cell donor registry participation: ~0.09% of eligible population (approximately 4 lakh registered donors in a country of 1.4 billion).
- DATRI, India's largest registry, has 6.6 lakh+ registered donors.
- 70% of aplastic anaemia patients do not find a match within their family and need an unrelated donor.
- Ideal transplant match: 10/10 at HLA-A, B, C, DRB1, DQB1 loci.
- Globally: 30+ million registered stem cell donors across 80+ registries in 57 countries.
- Germany (84 million population) has ~10 million registered donors — roughly 150 times India's rate per capita.
- Aplastic anaemia incidence may be 2–3× higher in Asia than in Western populations.
- Stem cell donation is typically a low-risk outpatient procedure using peripheral blood stem cell collection (PBSC method) in most cases.